DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.

[1]  R. Fåhraeus,et al.  Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation , 2011, Proceedings of the National Academy of Sciences.

[2]  J. Yewdell,et al.  Out with the old, in with the new? Comparing methods for measuring protein degradation , 2011, Cell biology international.

[3]  L. Eisenlohr,et al.  Hydrophobicity as a driver of MHC class I antigen processing , 2011, The EMBO journal.

[4]  P. Cresswell,et al.  A Genome-wide Multidimensional RNAi Screen Reveals Pathways Controlling MHC Class II Antigen Presentation , 2011, Cell.

[5]  R. Ferris,et al.  The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation. , 2011, Virology.

[6]  Kerstin Radtke,et al.  Alternative pathways for MHC class I presentation: a new function for autophagy , 2011, Cellular and Molecular Life Sciences.

[7]  P. Endert.  Providing ligands for MHC class I molecules , 2011, Cellular and Molecular Life Sciences.

[8]  Lewis Rubinson,et al.  A porcine model for initial surge mechanical ventilator assessment and evaluation of two limited-function ventilators* , 2011, Critical care medicine.

[9]  J. Yewdell,et al.  Distinct Pathways Generate Peptides from Defective Ribosomal Products for CD8+ T Cell Immunosurveillance , 2011, The Journal of Immunology.

[10]  L. Eisenlohr,et al.  Cutting Edge: Selective Role of Ubiquitin in MHC Class I Antigen Presentation , 2011, The Journal of Immunology.

[11]  D. Hartl,et al.  Misfolded proteins impose a dosage-dependent fitness cost and trigger a cytosolic unfolded protein response in yeast , 2010, Proceedings of the National Academy of Sciences.

[12]  R. Tampé,et al.  The transporter associated with antigen processing (TAP) is active in a post-ER compartment , 2010, Journal of Cell Science.

[13]  J. Yewdell,et al.  RNA Polymerase II Inhibitors Dissociate Antigenic Peptide Generation from Normal Viral Protein Synthesis: A Role for Nuclear Translation in Defective Ribosomal Product Synthesis? , 2010, The Journal of Immunology.

[14]  Ilan Beer,et al.  Soluble plasma HLA peptidome as a potential source for cancer biomarkers , 2010, Proceedings of the National Academy of Sciences.

[15]  R. Fåhraeus,et al.  Epstein Barr Virus-Encoded EBNA1 Interference with MHC Class I Antigen Presentation Reveals a Close Correlation between mRNA Translation Initiation and Antigen Presentation , 2010, PLoS pathogens.

[16]  D. Watkins,et al.  CD8+ T Cell Recognition of Cryptic Epitopes Is a Ubiquitous Feature of AIDS Virus Infection , 2010, Journal of Virology.

[17]  H. Yokosawa,et al.  BAG-6 is essential for selective elimination of defective proteasomal substrates , 2010, The Journal of cell biology.

[18]  G. Preti,et al.  In search of the chemical basis for MHC odourtypes , 2010, Proceedings of the Royal Society B: Biological Sciences.

[19]  P. Kloetzel,et al.  Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress , 2010, Cell.

[20]  F. Jotereau,et al.  Folding of Matrix Metalloproteinase-2 Prevents Endogenous Generation of MHC Class-I Restricted Epitope , 2010, PloS one.

[21]  J. Yewdell,et al.  mTORC1 Links Protein Quality and Quantity Control by Sensing Chaperone Availability*♦ , 2010, The Journal of Biological Chemistry.

[22]  S. Ben-Yehuda,et al.  Visualizing high error levels during gene expression in living bacterial cells , 2010, Proceedings of the National Academy of Sciences.

[23]  D. Wolf,et al.  Direct visualization of the dynamics of antigen presentation in human cells infected with cytomegalovirus revealed by antibodies mimicking TCR specificity , 2010, European journal of immunology.

[24]  Sébastien Lemieux,et al.  Deletion of Immunoproteasome Subunits Imprints on the Transcriptome and Has a Broad Impact on Peptides Presented by Major Histocompatibility Complex I molecules* , 2010, Molecular & Cellular Proteomics.

[25]  K. Davies,et al.  THE IMMUNOPROTEASOME, THE 20S PROTEASOME, AND THE PA28αβ PROTEASOME REGULATOR ARE OXIDATIVE STRESS‐ADAPTIVE PROTEOLYTIC COMPLEXES , 2010, The Biochemical journal.

[26]  K. Davies,et al.  THE IMMUNOPROTEASOME, THE 20S PROTEASOME, AND THE PA28{alpha}{beta} PROTEASOME REGULATOR ARE OXIDATIVE STRESS-ADAPTIVE PROTEOLYTIC COMPLEXES , 2010 .

[27]  D. Ganem,et al.  Making Sense of Antisense: Seemingly Noncoding RNAs Antisense to the Master Regulator of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Do Not Regulate That Transcript but Serve as mRNAs Encoding Small Peptides , 2010, Journal of Virology.

[28]  J. Yewdell,et al.  Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action , 2010, Proceedings of the National Academy of Sciences.

[29]  N. Shastri,et al.  The Synthesis of Truncated Polypeptides for Immune Surveillance and Viral Evasion , 2010, PloS one.

[30]  J. Yewdell,et al.  Defective Ribosomal Products Are the Major Source of Antigenic Peptides Endogenously Generated from Influenza A Virus Neuraminidase , 2009, The Journal of Immunology.

[31]  C. Evans,et al.  Neurons Preferentially Respond to Self-MHC Class I Allele Products Regardless of Peptide Presented , 2009, The Journal of Immunology.

[32]  A. Rickinson,et al.  T Cell Detection of a B-Cell Tropic Virus Infection: Newly-Synthesised versus Mature Viral Proteins as Antigen Sources for CD4 and CD8 Epitope Display , 2009, PLoS pathogens.

[33]  J. Yewdell,et al.  Innate Immune and Chemically Triggered Oxidative Stress Modifies Translational Fidelity , 2009, Nature.

[34]  E. Snapp,et al.  Fluorescent proteins: a cell biologist's user guide. , 2009, Trends in cell biology.

[35]  C. Shatz,et al.  MHC Class I: An Unexpected Role in Neuronal Plasticity , 2009, Neuron.

[36]  W. Gu,et al.  Both treated and untreated tumors are eliminated by short hairpin RNA-based induction of target-specific immune responses , 2009, Proceedings of the National Academy of Sciences.

[37]  P. Romero,et al.  Expression Hierarchy of T Cell Epitopes from Melanoma Differentiation Antigens: Unexpected High Level Presentation of Tyrosinase-HLA-A2 Complexes Revealed by Peptide-Specific, MHC-Restricted, TCR-Like Antibodies1 , 2009, The Journal of Immunology.

[38]  R. Lippé,et al.  Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection , 2009, Nature Immunology.

[39]  Qikai Xu,et al.  Global Protein Stability Profiling in Mammalian Cells , 2008, Science.

[40]  R. Fåhraeus,et al.  Gly-Ala Repeats Induce Position- and Substrate-specific Regulation of 26 S Proteasome-dependent Partial Processing* , 2008, Journal of Biological Chemistry.

[41]  N. Shastri,et al.  A Distinct Translation Initiation Mechanism Generates Cryptic Peptides for Immune Surveillance , 2008, PloS one.

[42]  B. García-Barreno,et al.  Relevance of viral context and diversity of antigen-processing routes for respiratory syncytial virus cytotoxic T-lymphocyte epitopes. , 2008, The Journal of general virology.

[43]  Keiji Tanaka,et al.  Allele-Selective Effect of PA28 in MHC Class I Antigen Processing1 , 2008, The Journal of Immunology.

[44]  T. Vuocolo,et al.  Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition , 2008, Proceedings of the National Academy of Sciences.

[45]  J. Yewdell,et al.  The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation. , 2008, Immunity.

[46]  J. Yewdell,et al.  Cutting Edge: MHC Class I–Ly49 Interaction Regulates Neuronal Function , 2008, The Journal of Immunology.

[47]  R. Tampé,et al.  Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation , 2008, Nature Immunology.

[48]  C. Nicchitta,et al.  Signal sequence- and translation-independent mRNA localization to the endoplasmic reticulum. , 2008, RNA.

[49]  U. Schubert,et al.  Targeting HIV-1 Gag into the Defective Ribosomal Product Pathway Enhances MHC Class I Antigen Presentation and CD8+ T Cell Activation1 , 2008, The Journal of Immunology.

[50]  M. Ceppi,et al.  Regulation of translation is required for dendritic cell function and survival during activation , 2007, The Journal of cell biology.

[51]  A. Hughes,et al.  AIDS virus–specific CD8+ T lymphocytes against an immunodominant cryptic epitope select for viral escape , 2007, The Journal of experimental medicine.

[52]  B. Kessler,et al.  A novel cytosolic class I antigen‐processing pathway for endoplasmic‐reticulum‐targeted proteins , 2007, EMBO reports.

[53]  L. Maquat,et al.  Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function. , 2007, Genes & development.

[54]  M. Marcilla,et al.  Proteasome-independent HLA-B27 Ligands Arise Mainly from Small Basic Proteins*S , 2007, Molecular & Cellular Proteomics.

[55]  L. Eisenlohr,et al.  Rethinking peptide supply to MHC class I molecules , 2007, Nature Reviews Immunology.

[56]  Sven Burgdorf,et al.  Distinct Pathways of Antigen Uptake and Intracellular Routing in CD4 and CD8 T Cell Activation , 2007, Science.

[57]  J. Yewdell,et al.  Viral Alteration of Cellular Translational Machinery Increases Defective Ribosomal Products , 2007, Journal of Virology.

[58]  J. Yewdell.  Plumbing the sources of endogenous MHC class I peptide ligands. , 2007, Current opinion in immunology.

[59]  Hans-Georg Rammensee,et al.  Distorted Relation between mRNA Copy Number and Corresponding Major Histocompatibility Complex Ligand Density on the Cell Surface*S , 2007, Molecular & Cellular Proteomics.

[60]  W. Green,et al.  Alternative Translational Products and Cryptic T Cell Epitopes: Expecting the Unexpected , 2006, The Journal of Immunology.

[61]  J. M. Grant,et al.  Cross‐priming utilizes antigen not available to the direct presentation pathway , 2006, Immunology.

[62]  J. Yewdell,et al.  The DRiP hypothesis decennial: support, controversy, refinement and extension. , 2006, Trends in immunology.

[63]  J. Yewdell,et al.  Tight Linkage between Translation and MHC Class I Peptide Ligand Generation Implies Specialized Antigen Processing for Defective Ribosomal Products1 , 2006, The Journal of Immunology.

[64]  K. Camphausen,et al.  Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy , 2006, The Journal of experimental medicine.

[65]  John A Tainer,et al.  Understanding GFP posttranslational chemistry: structures of designed variants that achieve backbone fragmentation, hydrolysis, and decarboxylation. , 2006, Journal of the American Chemical Society.

[66]  Ilan Beer,et al.  The Turnover Kinetics of Major Histocompatibility Complex Peptides of Human Cancer Cells* , 2006, Molecular & Cellular Proteomics.

[67]  V. Engelhard,et al.  Post-translational modifications of naturally processed MHC-binding epitopes. , 2006, Current opinion in immunology.

[68]  J. Yewdell,et al.  Characterization of Rapidly Degraded Polypeptides in Mammalian Cells Reveals a Novel Layer of Nascent Protein Quality Control* , 2006, Journal of Biological Chemistry.

[69]  R. Vabulas,et al.  Protein Synthesis upon Acute Nutrient Restriction Relies on Proteasome Function , 2005, Science.

[70]  Etienne Caron,et al.  The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome. , 2005, International immunology.

[71]  C. Nicchitta,et al.  Stable ribosome binding to the endoplasmic reticulum enables compartment-specific regulation of mRNA translation. , 2005, Molecular biology of the cell.

[72]  J. Yewdell.  The seven dirty little secrets of major histocompatibility complex class I antigen processing. , 2005, Immunological Reviews.

[73]  V. Engelhard,et al.  Regulated Folding of Tyrosinase in the Endoplasmic Reticulum Demonstrates That Misfolded Full-Length Proteins Are Efficient Substrates for Class I Processing and Presentation1 , 2005, The Journal of Immunology.

[74]  D. Jackson,et al.  The case for nuclear translation , 2004, Journal of Cell Science.

[75]  N. Shastri,et al.  Unanticipated Antigens: Translation Initiation at CUG with Leucine , 2004, PLoS biology.

[76]  E. Lund,et al.  Does protein synthesis occur in the nucleus? , 2004, Current opinion in cell biology.

[77]  P. Rohrlich,et al.  Identification of Cryptic MHC I–restricted Epitopes Encoded by HIV-1 Alternative Reading Frames , 2004, The Journal of experimental medicine.

[78]  M. Masucci.  Epstein–Barr virus oncogenesis and the ubiquitin–proteasome system , 2004, Oncogene.

[79]  J. Yewdell,et al.  Making sense of mass destruction: quantitating MHC class I antigen presentation , 2003, Nature Reviews Immunology.

[80]  J. Davoust,et al.  ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells , 2003, Nature.

[81]  N. Shastri,et al.  Constitutive Display of Cryptic Translation Products by MHC Class I Molecules , 2003, Science.

[82]  R. Fåhraeus,et al.  Self-Inhibition of Synthesis and Antigen Presentation by Epstein-Barr Virus-Encoded EBNA1 , 2003, Science.

[83]  F. Ginhoux,et al.  Quantifying Recruitment of Cytosolic Peptides for HLA Class I Presentation: Impact of TAP Transport1 , 2003, The Journal of Immunology.

[84]  Shu-Bing Qian,et al.  Quantitating protein synthesis, degradation, and endogenous antigen processing. , 2003, Immunity.

[85]  J. Yewdell,et al.  Systematic search fails to detect immunogenic MHC class-I-restricted determinants encoded by influenza A virus noncoding sequences. , 2003, Virology.

[86]  J. Yewdell.  To DRiP or not to DRiP: generating peptide ligands for MHC class I molecules from biosynthesized proteins. , 2002, Molecular immunology.

[87]  Jonathan W. Yewdell,et al.  A novel influenza A virus mitochondrial protein that induces cell death , 2001, Nature Medicine.

[88]  M. Buchmeier,et al.  Cutting Edge: Neosynthesis Is Required for the Presentation of a T Cell Epitope from a Long-Lived Viral Protein1 , 2001, The Journal of Immunology.

[89]  J. Yewdell.  Not such a dismal science: the economics of protein synthesis, folding, degradation and antigen processing. , 2001, Trends in cell biology.

[90]  J. Yewdell,et al.  At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class I molecules. , 2001, Journal of cell science.

[91]  J. Neefjes,et al.  The major substrates for TAP in vivo are derived from newly synthesized proteins , 2000, Nature.

[92]  Jonathan W. Yewdell,et al.  Rapid degradation of a large fraction of newly synthesized proteins by proteasomes , 2000, Nature.

[93]  C. Herberts,et al.  A single naturally processed measles virus peptide fully dominates the HLA‐A*0201‐associated peptide display and is mutated at its anchor position in persistent viral strains , 2000, European journal of immunology.

[94]  Jacques Neefjes,et al.  Head–head/tail–tail relative orientation of the pore-forming domains of the heterodimeric ABC transporter TAP , 2000, Current Biology.

[95]  J. Yewdell,et al.  Generating MHC class I ligands from viral gene products , 1999, Immunological reviews.

[96]  J. Yewdell,et al.  Intracellular Localization of Proteasomal Degradation of a Viral Antigen , 1999, The Journal of cell biology.

[97]  H. Rammensee,et al.  The making of the dominant MHC class I ligand SYFPEITHI , 1998, European journal of immunology.

[98]  J. Yewdell,et al.  Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides. , 1998, Journal of immunology.

[99]  J. Shabanowitz,et al.  The Class I Antigen-processing Pathway for the Membrane Protein Tyrosinase Involves Translation in the Endoplasmic Reticulum and Processing in the Cytosol , 1998, The Journal of experimental medicine.

[100]  J. Yewdell,et al.  Introduction of a Glycosylation Site into a Secreted Protein Provides Evidence for an Alternative Antigen Processing Pathway: Transport of Precursors of Major Histocompatability Complex Class I–Restricted Peptides from the Endoplasmic Reticulum to the Cytosol , 1997, The Journal of experimental medicine.

[101]  J. Yewdell,et al.  Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. , 1997, Immunity.

[102]  J. Yewdell,et al.  MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. , 1997, Journal of immunology.

[103]  R. Siliciano,et al.  Targeting of HIV-1 Antigens for Rapid Intracellular Degradation Enhances Cytotoxic T Lymphocyte (CTL) Recognition and the Induction of De Novo CTL Responses In Vivo After Immunization , 1997, The Journal of experimental medicine.

[104]  M. Fricker,et al.  Interphase Nuclei of Many Mammalian Cell Types Contain Deep, Dynamic, Tubular Membrane-bound Invaginations of the Nuclear Envelope , 1997, The Journal of cell biology.

[105]  L. Eisenlohr,et al.  Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames , 1996, The Journal of experimental medicine.

[106]  J. Yewdell,et al.  Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? , 1996, Journal of immunology.

[107]  S. Rosenberg,et al.  Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen , 1996, The Journal of experimental medicine.

[108]  N. Shastri,et al.  Major Histocompatibility Class I Molecules Can Present Cryptic Translation Products to T-cells (*) , 1995, The Journal of Biological Chemistry.

[109]  J. Bennink,et al.  RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes , 1992, The Journal of experimental medicine.

[110]  E. Gilboa,et al.  A frameshift mutation at the NH2 terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes. , 1991, Journal of immunology.

[111]  H. Rammensee,et al.  Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast , 1991, The Journal of experimental medicine.

[112]  D. Knowles.  Explanation and its Limits: List of Contributors , 1991 .

[113]  J. Yewdell,et al.  Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. , 1988, Science.

[114]  K. Gould,et al.  Cytotoxic T lymphocytes recognize influenza haemagglutinin that lacks a signal sequence , 1986, Nature.

[115]  J. Davey,et al.  Cytotoxic T cells recognize fragments of the influenza nucleoprotein , 1985, Cell.

[116]  S. Weissman,et al.  Biology of simian virus 40 (SV40) transplantation antigen (TrAg). IX. Analysis of TrAg in mouse cells synthesizing truncated SV40 large T antigen. , 1983, Virology.

[117]  D. Wheatley,et al.  Kinetics of degradation of "short-" and "long-lived" proteins in cultured mammalian cells. , 1980, Cell biology international reports.

[118]  M. J. Tevethia,et al.  Biology of simian virus 40 (SV40) transplantation antigen (TrAg) II. Isolation and characterization of additional temperature-sensitive mutants of SV40. , 1977, Virology.

[119]  M. Wibo,et al.  Protein degradation in cultured cells. The effect of fresh medium, fluoride, and iodoacetate on the digestion of cellular protein of rat fibroblasts. , 1973, The Journal of biological chemistry.

[120]  K. Piez,et al.  Protein turnover in mammaliar cell cultures. , 1959, The Journal of biological chemistry.

[121]  B. Wolf,et al.  Viral and bacterial minigene products are presented by MHC class I molecules with similar efficiencies. , 2011, Molecular immunology.

[122]  A. Schmidt.  Nonsense Mediated Decay Associated Pioneer Round of Translation as Source for Peptides for Presentation by MHC Class I , 2009 .

[123]  C. Nicchitta,et al.  Analysis of mRNA partitioning between the cytosol and endoplasmic reticulum compartments of mammalian cells. , 2008, Methods in molecular biology.

[124]  Kees Jalink,et al.  Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. , 2003, Immunity.

[125]  W Chen,et al.  Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. , 2000, Immunity.

[126]  P. Chomez,et al.  Genes coding for T-cell-defined tum transplantation antigens: point mutations, antigenic peptides, and subgenic expression. , 1989, Cold Spring Harbor symposia on quantitative biology.